Mark Brister

No open positions remaining

64 year

Health Technology

Profile

Mark Brister worked as a VP-Research & Development, Operations Director, Vice President-Vascular Research & Development, and Vice President-Research & Development at Arterial Vascular Engineering, Inc., Medtronic, Inc., and DexCom, Inc. respectively.
He also worked as a Vice President-Research & Development at Obalon Therapeutics, Inc.

Former positions of Mark Brister

Companies	Position	End
DEXCOM, INC.	Chief Tech/Sci/R&D Officer	2007-12-31
Medtronic, Inc. Medtronic, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for hypertension care	Corporate Officer/Principal	2002-12-31
Arterial Vascular Engineering, Inc. Arterial Vascular Engineering, Inc. Medical SpecialtiesHealth Technology Makes a variety of stent systems and balloon angioplasty catheters	Chief Operating Officer	1998-12-31
VYOME HOLDINGS, INC.	Chief Tech/Sci/R&D Officer	-

See the detail of Mark Brister's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Brister's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Medtronic, Inc. Medtronic, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for hypertension care	Health Technology
Arterial Vascular Engineering, Inc. Arterial Vascular Engineering, Inc. Medical SpecialtiesHealth Technology Makes a variety of stent systems and balloon angioplasty catheters	Health Technology
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical balloon technology for weight loss therapy	Health Technology
DexCom, Inc. DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians	Health Technology

See company connections

Stock Market
Insiders
Mark Brister